Hypogonadal
Drug research and approvals for hypogonadal: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 5 studies of hypogonadal are recruiting on ClinicalTrials.gov, and Health Canada has authorized 6 drug trials for it since 2013.
- Recruiting worldwide: 5
- Trials authorized in Canada: 6
- FDA orphan approvals: 0
- EU medicines: 0
Newest posted first, of 5 recruiting on ClinicalTrials.gov ↗
- Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active SurveillanceNCT07278362 · Phase 4 · University of Miami · starts Nov 30, 2026
- A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic AmenorrheaNCT07235917 · Phase 2 · Regeneron Pharmaceuticals · starts Mar 11, 2026
- Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate…NCT06733350 · Phase 4 · Roswell Park Cancer Institute · starts Jan 15, 2025
- Testosterone Treatment in Men With Chronic Kidney DiseaseNCT05249634 · Phase 2 · St. Louis University · starts Mar 15, 2022
- Testosterone Replacement in Male Cancer Survivors With Fatigue and Low TestosteroneNCT04049331 · Phase 2 · Seattle Institute for Biomedical and Clinical Research · starts Mar 22, 2021
Newest first; search them all in Canada trials
| Sep 21, 2018 | A five-arm, randomized, crossover study to determine the exposure of testosterone and dihydrotestosterone when SOV2012-F1 is dosed fasted, with meals of…Testosterone undecanoate | Marius Pharmaceuticals | Closed |
| Sep 15, 2016 | A 150-day, prospective, phase 4, open-label study, evaluating patient satisfaction and symptom improvement when treating male hypogonadism with testosterone…Testosterone | Acerus Pharmaceuticals | Closed |
| Dec 29, 2014 | Open-label, randomized, four period, four treatment, cross-over, single dose study to evaluate bioavailability and pharmacokinetics of oral testosterone…Testosterone undecanoate | Lipocine Inc | Ongoing |
| Apr 8, 2014 | Open label, four period, dose escalating single and multiple dose study to determine safety, tolerability and pharmacokinetics of testosterone tridecanoate…Testosterone | Lipocine Inc | Closed |
| Oct 4, 2013 | Open-label, 4-part, multiple-dose study to evaluate the pharmacokinetic profile, safety, and tolerability of different doses of testosterone undecanoate in…Testosterone | Sov Therapeutics Inc | Closed |
| May 2, 2013 | A randomized, double-blind, placebo-controlled parallel study with an open-label extension to assess the impact of testosterone solution on total testosterone,…Axiron (testosterone) | Eli Lilly | Closed |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA